Amgen Earnings, Revenue beat In Q2

  • Investing.com
  • Stock Market News
Amgen Earnings, Revenue beat In Q2
Credit: © Reuters.

Investing.com - Amgen (NASDAQ: AMGN ) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Amgen announced earnings per share of $4.65 on revenue of $6.59B. Analysts polled by Investing.com anticipated EPS of $4.39 on revenue of $6.53B.

Amgen shares are up 9% from the beginning of the year and are trading at $247.90 , down-from-52-week-high.They are outperforming the Nasdaq 100 which is down 18.44% from the start of the year.

Amgen shares gained 0.37% in after-hours trade the report.

Amgen follows other major Healthcare sector earnings this month

Amgen's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.

J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100